highperformr logo

Lupin's Overview

Total employees19761
HeadquartersMumbai
Founded

Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai, Maharashtra, India. It is one of the largest generic pharmaceutical companies by revenue globally. Lupin's key therapeutic areas include pediatrics, cardiovascular, anti-infectives, diabetology, asthma, and anti-tuberculosis. The company is committed to providing affordable and innovative medicines for a healthier world, with a significant presence in research, manufacturing, and marketing across numerous countries.

Where is Lupin's Headquarters?

HQ Function

The Mumbai headquarters serves as the central hub for Lupin's global strategy, corporate governance, research and development oversight, financial management, and key operational decisions.

Notable Features:

Located in Kalpataru Inspire, a modern commercial complex, the headquarters features state-of-the-art infrastructure, designed to foster collaboration, innovation, and efficient global management. It likely includes advanced workspaces, meeting facilities, and employee amenities.

Work Culture:

Lupin fosters a work culture rooted in its core values of integrity, teamwork, respect for people, customer focus, entrepreneurship, and excellence. The HQ environment is dynamic, research-driven, and focused on achieving global healthcare objectives and improving patient lives.

HQ Significance:

The headquarters is significant as the command center for one of the world's leading pharmaceutical companies, driving innovation in drug development, managing a vast global supply chain, and steering the company's growth in over 100 countries.

Values Reflected in HQ: The headquarters' modern architecture, strategic location, and advanced facilities reflect Lupin's commitment to innovation, global connectivity, operational excellence, and providing a conducive environment for its employees.

Location:

Lupin has a significant global footprint, marketing its products in over 100 countries. Key functions supported globally include Research & Development (with centers in India, USA, Netherlands, Brazil, Mexico), advanced Manufacturing (facilities in India, USA, Mexico, Brazil), Marketing & Sales, a robust Supply Chain network, stringent Quality Assurance, and comprehensive Regulatory Affairs management across all its operational regions.

Street Address:

Lupin Limited, Kalpataru Inspire, 3rd Floor, Off Western Express Highway, Santacruz (East)

City:

Mumbai

State/Province:

Maharashtra

Country:

India

Lupin's Global Presence

Bridgewater, New Jersey, USA

Address: Lupin Somerset, 200 Crossing Boulevard, Bridgewater, NJ 08807, USA

Drives growth and market presence in North America, focusing on providing affordable and innovative medicines to patients in the U.S. and Canada. Supports regulatory affairs, strategic partnerships, and product distribution within the region.

Zug, Switzerland

Address: Lupin Atlantis Holdings SA, Industriestrasse 1, 6300 Zug, Switzerland

Coordinates Lupin's expansion and market access strategies in Europe, ensuring compliance with regional pharmaceutical regulations and fostering partnerships to enhance product availability.

Buying Intent Signals for Lupin

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Lupin

As of April 2025, Lupin' leadership includes:

Vinita Gupta - Chief Executive Officer
Nilesh Gupta - Managing Director
Dr. Ranjana Pathak - Chief Quality Officer
Sreeji Gopinathan - Chief Information Officer
Spiro Gavaris - President - U.S. Generics

Investors of Lupin

Lupin has been backed by several prominent investors over the years, including:

Promoter Group (Gupta Family)
Life Insurance Corporation of India (LIC)
Various Foreign Institutional Investors (FIIs)
Domestic Institutional Investors (DIIs) & Mutual Funds

Executive New Hires/Exits in the Last 12 Months

Hire3
Exits2

Lupin has experienced key leadership transitions over the past 12-18 months, particularly strengthening its U.S. operations with a new CEO and announcing a new Group CFO to steer its global financial strategy. These changes reflect the company's focus on driving growth in key markets and enhancing its leadership capabilities.

Departures

Ramesh Swaminathan, Ramesh Swaminathan retired as Global CFO and Head - Corporate Affairs on December 31, 2023.
Spiros Fikardos, Spiros Fikardos stepped down as CEO of Lupin Inc. and was succeeded by Abdelaziz Toumi.

New Appointments:

Christoph Funke, Christoph Funke appointed as Chief Financial Officer, effective October 1, 2024.
Abdelaziz (Aziz) Toumi, Abdelaziz Toumi appointed as CEO of Lupin Inc., effective May 15, 2023.
Dr. Shahin Fesharaki, Dr. Shahin Fesharaki appointed as CEO of Lupin's new AMPIS (Access to Medicines & Medical Products for an Improved & Sustainable Society) unit.

Technology (Tech Stack) used by Lupin

Discover the tools Lupin uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Lupin Email Formats and Examples

Lupin commonly uses professional email address formats that combine an employee's name with the company domain '@lupin.com'. The most prevalent formats include using the first initial followed by the last name, or the full first name separated from the last name by a period.

[firstinitial][lastname]@lupin.com or [firstname].[lastname]@lupin.com

Format

vgupta@lupin.com (example for Vinita Gupta based on common pattern)

Example

85%

Success rate

News and media

lupin.com (Press Release)May 9, 2024

Lupin Reports All-Round Performance for Q4 and FY2024

Lupin Limited announced its financial results for the fourth quarter and full year ending March 31, 2024. The company reported strong growth in revenue, particularly in its U.S. operations, and improved profitability, driven by new product launches and enhanced operational efficiencies....more

lupin.com (Press Release)April 23, 2024

Lupin Receives U.S. FDA Approval for Febuxostat Tablets

Lupin announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Febuxostat Tablets, 40 mg and 80 mg. Febuxostat Tablets are indicated for the chronic management of hyperuricemia in adult patients with gout....more

lupin.com (Press Release)March 18, 2024

Lupin Launches First Generic Version of Oracea® (Doxycycline Capsules, 40 mg) in Canada

Lupin's subsidiary, Lupin Pharma Canada Ltd., announced the launch of the first generic version of Oracea® (Doxycycline Capsules USP, 40 mg) in Canada, having received approval from Health Canada. This launch expands Lupin's dermatology portfolio in Canada....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Lupin, are just a search away.